SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-018586
Filing Date
2022-05-06
Accepted
2022-05-06 16:19:02
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elox-10q_20220331.htm   iXBRL 10-Q 1732084
2 EX-31.1 elox-ex311_6.htm EX-31.1 8703
3 EX-31.2 elox-ex312_12.htm EX-31.2 9231
4 EX-32.1 elox-ex321_10.htm EX-32.1 7028
5 EX-32.2 elox-ex322_11.htm EX-32.2 6858
  Complete submission text file 0001564590-22-018586.txt   5238245

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA elox-20220331.xsd EX-101.SCH 41838
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elox-20220331_cal.xml EX-101.CAL 38864
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elox-20220331_def.xml EX-101.DEF 80038
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20220331_lab.xml EX-101.LAB 290327
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20220331_pre.xml EX-101.PRE 213373
55 EXTRACTED XBRL INSTANCE DOCUMENT elox-10q_20220331_htm.xml XML 731984
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 22901343
SIC: 2836 Biological Products, (No Diagnostic Substances)